Jean-michel M. Cayuela

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Persistent BCR::ABL1-positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome-positive ALL.

Persistent BCR::ABL1-positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome-positive ALL.

Journal: HemaSphere

Published: March 11, 2026

Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi-LMC study.

Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi-LMC study.

Journal: HemaSphere

Published: February 26, 2026

Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial.

Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial.

Journal: The Lancet. Haematology

Published: August 18, 2025

The contribution of high-throughput sequencing in malignant hematological disorders

The contribution of high-throughput sequencing in malignant hematological disorders

Journal: La Revue du praticien

Published: June 23, 2025

Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome.

Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome.

Journal: The journal of allergy and clinical immunology. In practice

Published: March 11, 2025

Recommendations from the GBMHM and the Fi-LMC for the diagnosis and management of chronic myeloid leukemia

Recommendations from the GBMHM and the Fi-LMC for the diagnosis and management of chronic myeloid leukemia

Journal: Bulletin du cancer

Published: March 07, 2025

Implementation science in hemato-oncology molecular diagnostics in France via the Groupe des Biologistes Moléculaire des Hémopathies Malignes (GBMHM).

Implementation science in hemato-oncology molecular diagnostics in France via the Groupe des Biologistes Moléculaire des Hémopathies Malignes (GBMHM).

Journal: HemaSphere

Published: March 05, 2025

Treatment-free remission in chronic myeloid leukemia with rare ABL1 gene fusions: Real-life study from the French CML group Fi-LMC.

Treatment-free remission in chronic myeloid leukemia with rare ABL1 gene fusions: Real-life study from the French CML group Fi-LMC.

Journal: Leukemia research

Published: February 05, 2025

Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study.

Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study.

Journal: American journal of hematology

Published: September 12, 2024

Recurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients.

Recurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients.

Journal: Histopathology

Published: August 10, 2024

Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL: A GRAAPH-2014 Study.

Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL: A GRAAPH-2014 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 19, 2024

Asciminib resistance of a new BCR::ABL1 p.I293_K294insSSLRD mutant detected in a Ph + ALL patient.

Asciminib resistance of a new BCR::ABL1 p.I293_K294insSSLRD mutant detected in a Ph + ALL patient.

Journal: Annals of hematology

Published: May 02, 2024

Showing 1-12 of 87

Last Updated: 09/26/2026